Security key
81749D107
CUSIP: 81749D107
Security key
81749D107
Report period
Q3 2023
Institutions
27
Top holders
10
Broader feeds
Reporting periods
Recent filing periods:
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO |
13F
|
Company |
6.3%
|
2,416,241
|
$7,961,514 | — | 30 Jun 2023 | |
| Vivo Capital, LLC |
13F
|
Company |
4.8%
|
1,856,011
|
$6,115,556 | — | 30 Jun 2023 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
4.6%
|
1,777,435
|
$5,856,648 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
2%
|
773,428
|
$2,548,445 | — | 30 Jun 2023 | |
| Fosun International Ltd |
13F
|
Company |
1.4%
|
554,148
|
$1,825,918 | — | 30 Jun 2023 | |
| Informed Momentum Co LLC |
13F
|
Company |
1%
|
387,193
|
$1,275,801 | — | 30 Jun 2023 | |
| CAPTRUST FINANCIAL ADVISORS |
13F
|
Company |
0.99%
|
381,737
|
$1,257,823 | — | 30 Jun 2023 | |
| SANDERS MORRIS HARRIS LLC |
13F
|
Company |
0.94%
|
363,172
|
$1,196,652 | — | 30 Jun 2023 | |
| Acuitas Investments, LLC |
13F
|
Company |
0.45%
|
173,202
|
$570,701 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.38%
|
145,486
|
$479,376 | — | 30 Jun 2023 | |
| Riverview Capital Advisers, LLC |
13F
|
Company |
0.27%
|
102,731
|
$338,499 | — | 30 Jun 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
73,305
|
$241,540 | — | 30 Jun 2023 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.18%
|
70,588
|
$233,000 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.16%
|
59,918
|
$197,430 | — | 30 Jun 2023 | |
| Requisite Capital Management, LLC |
13F
|
Company |
0.14%
|
55,648
|
$183,360 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.13%
|
50,192
|
$165,383 | — | 30 Jun 2023 | |
| RESOURCE CONSULTING GROUP INC |
13F
|
Company |
0.12%
|
46,734
|
$153,989 | — | 30 Jun 2023 | |
| Marquette Asset Management, LLC |
13F
|
Company |
0.09%
|
35,687
|
$117,589 | — | 30 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.07%
|
27,191
|
$89,594 | — | 30 Jun 2023 | |
| UBS Group AG |
13F
|
Company |
0.06%
|
23,326
|
$76,859 | — | 30 Jun 2023 | |
| Prime Capital Investment Advisors, LLC |
13F
|
Company |
0.05%
|
21,000
|
$69,195 | — | 30 Jun 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.05%
|
19,921
|
$65,640 | — | 30 Jun 2023 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.05%
|
18,108
|
$59,666 | — | 30 Jun 2023 | |
| MAI Capital Management |
13F
|
Company |
0.04%
|
16,989
|
$55,979 | — | 30 Jun 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
15,400
|
$50,743 | — | 30 Jun 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
12,997
|
$42,825 | — | 30 Jun 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
12,087
|
$39,827 | — | 30 Jun 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.03%
|
12,000
|
$39,540 | — | 30 Jun 2023 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
0.03%
|
10,000
|
$32,950 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
3,769
|
$12,419 | — | 30 Jun 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
959
|
$3,160 | — | 30 Jun 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
168
|
$1,000 | — | 30 Jun 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
98
|
$323 | — | 30 Jun 2023 | |
| Blue Ox Healthcare Partners, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
256,665
|
$1,339,791 | — | 18 Jul 2022 | |
| Douglas Carl Fisher |
3/4/5
|
Chief Business Officer |
—
class O/S missing
|
220,562
|
$1,151,334 | — | 10 Jan 2022 | |
| Jay M. Moyes |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
87,430
mixed-class rows
|
$185,989 | — | 07 Jun 2023 | |
| Michael R. Foley |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
69,700
mixed-class rows
|
$140,940 | — | 12 Jul 2023 | |
| Nadia Altomare |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
47,200
mixed-class rows
|
$95,526 | — | 09 Jun 2023 | |
| Thomas Garite |
3/4/5
|
VP, Clinical Sciences |
—
class O/S missing
|
10,000
|
— | — | 26 Aug 2021 |
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).